Your browser doesn't support javascript.
loading
Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma.
Chen, Liangyuan; Kang, Yanli; Jiang, Yingfeng; You, Jianbin; Huang, Chen; Xu, Xunyu; Chen, Falin.
Afiliación
  • Chen L; Department of Clinical Laboratory, Fujian Provincial hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Kang Y; Department of Clinical Laboratory, Fujian Provincial hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Jiang Y; Department of Clinical Laboratory, Fujian Provincial hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • You J; Department of Clinical Laboratory, Fujian Provincial hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Huang C; Department of Thoracic Surgery, Fujian Provincial hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China.
  • Xu X; Department of Thoracic Surgery, Fujian Provincial hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. Electronic address: xunyuxu@sina.com.
  • Chen F; Department of Clinical Laboratory, Fujian Provincial hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, China. Electronic address: chenfalin008@126.com.
Pathol Res Pract ; 237: 154031, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35878532

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pathol Res Pract Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Adenocarcinoma / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pathol Res Pract Año: 2022 Tipo del documento: Article País de afiliación: China